_id
6910583bccc777a4e85d56d7
Ticker
CYAN
Name
Cyanotech Corporation
Exchange
NASDAQ
Address
73-4460 Queen Kaahumanu Highway, Kailua-Kona, HI, United States, 96740
Country
USA
Sector
Consumer Defensive
Industry
Packaged Foods
Currency
USD
Website
https://www.cyanotech.com
Description
Cyanotech Corporation, an agricultural company, engages in the production and sale of natural ingredients and dietary supplement products from microalgae for health and wellness markets. The company offers BioAstin Hawaiian Astaxanthin, a natural antioxidant to enhance skin, and to support eye, joint, brain, and immune health; and Hawaiian Spirulina Pacifica, a nutrient-rich dietary supplement to support natural energy, immune system, and cardiovascular health, as well as a source of protein, antioxidant carotenoids, and essential nutrients. It also provides contract extraction, and research and development services. The company sells its products through distributors, retailers, and online channels; direct to consumers; and in bulk form to manufacturers, formulators, and distributors in the health food, cosmetic manufacturers and nutraceuticals, and dietary supplement markets. It operates in the United States, the Asia-Pacific, Europe, and internationally. Cyanotech Corporation was incorporated in 1983 and is headquartered in Kailua-Kona, Hawaii.
Last Close
0.45
Volume
-
Current Price
0.39
Change
-13.333333333333334
Last Updated
2025-11-29T12:04:18.682Z
Image
-
Ipo Date
1993-06-22T00:00:00.000Z
Market Cap
2824474
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Current Quarter
2025-09-30
Revenue
6976000
Cost Of Revenue
4583000
Gross Profit
2393000
Operating Expenses
2203000
Operating Income
190000
Interest Expense
189000
Pretax Income
1000
Net Income
1000
Eps
0.0001371177841766077
Dividends Per Share
-
Shares Outstanding
7242243
Income Tax Expense
-
EBITDA
672000
Operating Margin
2.7236238532110093
Total Other Income Expense Net
-189000
Cash
649000
Short Term Investments
-
Receivables
2354000
Inventories
8378000
Total Current Assets
11931000
Property Plant Equipment
3632000
Total Assets
24027000
Payables
2971000
Short Term Debt
7934000
Long Term Debt
1000000
Total Liabilities
15962000
Equity
8065000
Depreciation
482000
Change In Working Capital
-48000
Cash From Operations
108000
Capital Expenditures
64000
Cash From Investing
-64000
Cash From Financing
222000
Net Change In Cash
266000
PE
-
PB
0.40692498450092995
ROE
0.012399256044637322
ROA
0.0041619844341782165
FCF
44000
Fcf Percent
0.006307339449541285
Piotroski FScore
4
Health Score
39
Deep Value Investing Score
8.5
Defensive Investing Score
5.5
Dividend Investing Score
3
Economic Moat Investing Score
4.8
Garp Investing Score
4
Growth Investing Score
3.5
Momentum Investing Score
2.5
Net Net Investing Score
2.5
Quality Investing Score
4.5
Value Investing Score
7.5
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
6976000
Quarters > 0 > income Statement > cost Of Revenue
4583000
Quarters > 0 > income Statement > gross Profit
2393000
Quarters > 0 > income Statement > operating Expenses
2203000
Quarters > 0 > income Statement > operating Income
190000
Quarters > 0 > income Statement > interest Expense
189000
Quarters > 0 > income Statement > pretax Income
1000
Quarters > 0 > income Statement > net Income
1000
Quarters > 0 > income Statement > eps
0.0001371177841766077
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
7293000
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
672000
Quarters > 0 > income Statement > operating Margin
2.7236238532110093
Quarters > 0 > income Statement > total Other Income Expense Net
-189000
Quarters > 0 > balance Sheet > cash
649000
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
2354000
Quarters > 0 > balance Sheet > inventories
8378000
Quarters > 0 > balance Sheet > total Current Assets
11931000
Quarters > 0 > balance Sheet > property Plant Equipment
3632000
Quarters > 0 > balance Sheet > total Assets
24027000
Quarters > 0 > balance Sheet > payables
2971000
Quarters > 0 > balance Sheet > short Term Debt
7934000
Quarters > 0 > balance Sheet > long Term Debt
1000000
Quarters > 0 > balance Sheet > total Liabilities
15962000
Quarters > 0 > balance Sheet > equity
8065000
Quarters > 0 > cash Flow > net Income
1000
Quarters > 0 > cash Flow > depreciation
482000
Quarters > 0 > cash Flow > change In Working Capital
-48000
Quarters > 0 > cash Flow > cash From Operations
108000
Quarters > 0 > cash Flow > capital Expenditures
64000
Quarters > 0 > cash Flow > cash From Investing
-64000
Quarters > 0 > cash Flow > cash From Financing
222000
Quarters > 0 > cash Flow > net Change In Cash
266000
Quarters > 0 > ratios > PE
0.0001371177841766077
Quarters > 0 > ratios > PB
0.40692498450092995
Quarters > 0 > ratios > ROE
0.012399256044637322
Quarters > 0 > ratios > ROA
0.0041619844341782165
Quarters > 0 > ratios > FCF
44000
Quarters > 0 > ratios > Piotroski FScore
4
Quarters > 0 > ratios > fcf Percent
0.006307339449541285
Quarters > 0 > health Score
39
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
5820000
Quarters > 1 > income Statement > cost Of Revenue
4047000
Quarters > 1 > income Statement > gross Profit
1773000
Quarters > 1 > income Statement > operating Expenses
2526000
Quarters > 1 > income Statement > operating Income
-753000
Quarters > 1 > income Statement > interest Expense
173000
Quarters > 1 > income Statement > pretax Income
-926000
Quarters > 1 > income Statement > net Income
-926000
Quarters > 1 > income Statement > eps
-0.128414921647483
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
7211000
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
-258000
Quarters > 1 > income Statement > operating Margin
-12.93814432989691
Quarters > 1 > income Statement > total Other Income Expense Net
-173000
Quarters > 1 > balance Sheet > cash
383000
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
1560000
Quarters > 1 > balance Sheet > inventories
8110000
Quarters > 1 > balance Sheet > total Current Assets
10523000
Quarters > 1 > balance Sheet > property Plant Equipment
12359000
Quarters > 1 > balance Sheet > total Assets
22995000
Quarters > 1 > balance Sheet > payables
2234000
Quarters > 1 > balance Sheet > short Term Debt
7698000
Quarters > 1 > balance Sheet > long Term Debt
1000000
Quarters > 1 > balance Sheet > total Liabilities
14995000
Quarters > 1 > balance Sheet > equity
8000000
Quarters > 1 > cash Flow > net Income
-926000
Quarters > 1 > cash Flow > depreciation
495000
Quarters > 1 > cash Flow > change In Working Capital
48000
Quarters > 1 > cash Flow > cash From Operations
-328000
Quarters > 1 > cash Flow > capital Expenditures
22000
Quarters > 1 > cash Flow > cash From Investing
-22000
Quarters > 1 > cash Flow > cash From Financing
476000
Quarters > 1 > cash Flow > net Change In Cash
126000
Quarters > 1 > ratios > PE
-0.128414921647483
Quarters > 1 > ratios > PB
0.40561875000000003
Quarters > 1 > ratios > ROE
-11.575000000000001
Quarters > 1 > ratios > ROA
-4.026962383126767
Quarters > 1 > ratios > FCF
-350000
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-0.06013745704467354
Quarters > 1 > health Score
24
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
6300000
Quarters > 2 > income Statement > cost Of Revenue
4558000
Quarters > 2 > income Statement > gross Profit
1742000
Quarters > 2 > income Statement > operating Expenses
2184000
Quarters > 2 > income Statement > operating Income
-442000
Quarters > 2 > income Statement > interest Expense
177000
Quarters > 2 > income Statement > pretax Income
-619000
Quarters > 2 > income Statement > net Income
-627000
Quarters > 2 > income Statement > eps
-0.08867204072974119
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
7071000
Quarters > 2 > income Statement > income Tax Expense
8000
Quarters > 2 > income Statement > EBITDA
46000
Quarters > 2 > income Statement > operating Margin
-7.015873015873016
Quarters > 2 > income Statement > total Other Income Expense Net
-177000
Quarters > 2 > balance Sheet > cash
257000
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
1953000
Quarters > 2 > balance Sheet > inventories
7788000
Quarters > 2 > balance Sheet > total Current Assets
10545000
Quarters > 2 > balance Sheet > property Plant Equipment
12829000
Quarters > 2 > balance Sheet > total Assets
23490000
Quarters > 2 > balance Sheet > payables
2217000
Quarters > 2 > balance Sheet > short Term Debt
7201000
Quarters > 2 > balance Sheet > long Term Debt
1000000
Quarters > 2 > balance Sheet > total Liabilities
14606000
Quarters > 2 > balance Sheet > equity
8884000
Quarters > 2 > cash Flow > net Income
-627000
Quarters > 2 > cash Flow > depreciation
488000
Quarters > 2 > cash Flow > change In Working Capital
64000
Quarters > 2 > cash Flow > cash From Operations
-57000
Quarters > 2 > cash Flow > capital Expenditures
84000
Quarters > 2 > cash Flow > cash From Investing
-84000
Quarters > 2 > cash Flow > cash From Financing
39000
Quarters > 2 > cash Flow > net Change In Cash
-102000
Quarters > 2 > ratios > PE
-0.08867204072974119
Quarters > 2 > ratios > PB
0.35816636650157585
Quarters > 2 > ratios > ROE
-7.057631697433589
Quarters > 2 > ratios > ROA
-2.669220945083014
Quarters > 2 > ratios > FCF
-141000
Quarters > 2 > ratios > Piotroski FScore
1
Quarters > 2 > ratios > fcf Percent
-0.02238095238095238
Quarters > 2 > health Score
24
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
6172000
Quarters > 3 > income Statement > cost Of Revenue
3993000
Quarters > 3 > income Statement > gross Profit
2179000
Quarters > 3 > income Statement > operating Expenses
2229000
Quarters > 3 > income Statement > operating Income
-50000
Quarters > 3 > income Statement > interest Expense
174000
Quarters > 3 > income Statement > pretax Income
-224000
Quarters > 3 > income Statement > net Income
-224000
Quarters > 3 > income Statement > eps
-0.03130240357741755
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
7156000
Quarters > 3 > income Statement > income Tax Expense
-
Quarters > 3 > income Statement > EBITDA
450000
Quarters > 3 > income Statement > operating Margin
-0.8101101749837978
Quarters > 3 > income Statement > total Other Income Expense Net
-174000
Quarters > 3 > balance Sheet > cash
359000
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
1908000
Quarters > 3 > balance Sheet > inventories
7751000
Quarters > 3 > balance Sheet > total Current Assets
10551000
Quarters > 3 > balance Sheet > property Plant Equipment
4032000
Quarters > 3 > balance Sheet > total Assets
23956000
Quarters > 3 > balance Sheet > payables
2151000
Quarters > 3 > balance Sheet > short Term Debt
7140000
Quarters > 3 > balance Sheet > long Term Debt
1000000
Quarters > 3 > balance Sheet > total Liabilities
14456000
Quarters > 3 > balance Sheet > equity
9500000
Quarters > 3 > cash Flow > net Income
-224000
Quarters > 3 > cash Flow > depreciation
500000
Quarters > 3 > cash Flow > change In Working Capital
-1268000
Quarters > 3 > cash Flow > cash From Operations
-935000
Quarters > 3 > cash Flow > capital Expenditures
58000
Quarters > 3 > cash Flow > cash From Investing
-58000
Quarters > 3 > cash Flow > cash From Financing
572000
Quarters > 3 > cash Flow > net Change In Cash
-421000
Quarters > 3 > ratios > PE
-0.03130240357741755
Quarters > 3 > ratios > PB
0.3389684210526316
Quarters > 3 > ratios > ROE
-2.3578947368421055
Quarters > 3 > ratios > ROA
-0.9350475872432793
Quarters > 3 > ratios > FCF
-993000
Quarters > 3 > ratios > Piotroski FScore
0
Quarters > 3 > ratios > fcf Percent
-0.16088788075178223
Quarters > 3 > health Score
23
Valuation > metrics > PE
0.0001371177841766077
Valuation > metrics > PB
0.40692498450092995
Valuation > final Score
90
Valuation > verdict
79.7% Undervalued
Profitability > metrics > ROE
0.012399256044637322
Profitability > metrics > ROA
0.008381527114240214
Profitability > metrics > Net Margin
0.00014334862385321102
Profitability > final Score
0
Profitability > verdict
Weak
Risk > metrics > Debt Equity
1.9791692498450093
Risk > metrics > Interest Coverage
1.0052910052910053
Risk > final Score
34
Risk > verdict
High
Liquidity > metrics > Current Ratio
1.0940852819807427
Liquidity > metrics > Quick Ratio
0.32581384685923886
Liquidity > final Score
44
Liquidity > verdict
Weak
Prev Valuations > 0
70
Prev Valuations > 1
70
Prev Valuations > 2
70
Prev Profitabilities > 0
0
Prev Profitabilities > 1
0
Prev Profitabilities > 2
0
Prev Risks > 0
13
Prev Risks > 1
20
Prev Risks > 2
29
Prev Liquidities > 0
39
Prev Liquidities > 1
43
Prev Liquidities > 2
43
Updated At
2025-12-16T13:45:16.147Z
Cyanotech Corporation, an agricultural company, engages in the production and sale of natural ingredients and dietary supplement products from microalgae for health and wellness markets. The company offers BioAstin Hawaiian Astaxanthin, a natural antioxidant to enhance skin, and to support eye, joint, brain, and immune health; and Hawaiian Spirulina Pacifica, a nutrient-rich dietary supplement to support natural energy, immune system, and cardiovascular health, as well as a source of protein, antioxidant carotenoids, and essential nutrients. It also provides contract extraction, and research and development services. The company sells its products through distributors, retailers, and online channels; direct to consumers; and in bulk form to manufacturers, formulators, and distributors in the health food, cosmetic manufacturers and nutraceuticals, and dietary supplement markets. It operates in the United States, the Asia-Pacific, Europe, and internationally. Cyanotech Corporation was incorporated in 1983 and is headquartered in Kailua-Kona, Hawaii.
Stock Price
$ 0.00
0% decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/AWall Street Sees Muted Reaction After Noisy Jobs: Markets Wrap Bloomberg.com
Read more →Stock exchanges, winds of peace sink defence and oil. Fincantieri thud in Milan (-0.3%), spread at lowest level since 2009 Il Sole 24 ORE
Read more →Showing 2 of 10
(Last Updated 2025-09-30)
Health Score
Price to Book Ratio (P/B)
-
Very Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very Low
Low ≤ 5%
High ≥ 15%
Debt to Equity
-
Very Low
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.04% of the total shares of Cyanotech Corporation
1.
SSgA U.S. Extended Market Index Class I(0.0396%)
since
2023/12/31
2.
NT US Market Cap Idx Fd - L(0.0049%)
since
2023/12/31
3.
Northern Trust Investments N A(0%)
since
2024/12/31
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
No earnings data available.
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.